Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tracon Pharmaceuticals, Inc. | 4,606,094 | reported | 29 Nov 2018 | tx 2+8,652 |
| Bellerophon Therapeutics, Inc. | 0 | reported | 13 Oct 2023 | tx 4+1,294,467−1,076,841 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Oct 2023 | SALE | Bellerophon Therapeutics, Inc. | 1,076,841 | 0.10 USD | |
| 26 Apr 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 609,231 | 4.00 USD | |
| 26 Apr 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 380,950 | 0.00 USD | deriv |
| 26 Apr 2021 | GRANT_AWARD | Bellerophon Therapeutics, Inc. | 304,286 | 0.00 USD | deriv |
| 29 Nov 2018 | SALE | Tracon Pharmaceuticals, Inc. | 4,326 | 1.21 USD | |
| 29 Nov 2018 | PURCHASE | Tracon Pharmaceuticals, Inc. | 4,326 | 1.13 USD |